These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4678500)

  • 1. The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity?
    Volpe R; Edmonds M; Lamki L; Clarke PV; Row VV
    Mayo Clin Proc; 1972 Nov; 47(11):824-34. PubMed ID: 4678500
    [No Abstract]   [Full Text] [Related]  

  • 2. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA
    J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract]   [Full Text] [Related]  

  • 4. The choices of therapy in Graves' disease.
    Stanbury JB
    Med Times; 1970 Nov; 98(11):105-20. PubMed ID: 4097048
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis.
    Field EJ; Caspary EA; Hall R; Clark F
    Lancet; 1970 May; 1(7657):1144-7. PubMed ID: 4192099
    [No Abstract]   [Full Text] [Related]  

  • 6. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
    Hall R; Kirkham K; Doniach D; el-Kabir D
    Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
    [No Abstract]   [Full Text] [Related]  

  • 7. Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease.
    Wasnich RD; Grumet FC; Payne RO; Kriss JP
    J Clin Endocrinol Metab; 1973 Nov; 37(5):703-13. PubMed ID: 4800434
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoantibodies against TSH-receptor in Graves' disease (author's transl)].
    Shishiba Y
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1567-72. PubMed ID: 6262419
    [No Abstract]   [Full Text] [Related]  

  • 9. Graves' disease--1972.
    Solomon DH; Chopra IJ
    Mayo Clin Proc; 1972 Nov; 47(11):803-13. PubMed ID: 4678498
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 11. Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease.
    Orth DN
    J Tenn Med Assoc; 1967 Jan; 60(1):41-7. PubMed ID: 5343003
    [No Abstract]   [Full Text] [Related]  

  • 12. [The long-acting thyroid stimulator (LATS)].
    Masala C
    Folia Allergol (Roma); 1969; 16(3):249-63. PubMed ID: 4931876
    [No Abstract]   [Full Text] [Related]  

  • 13. [LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1969 Oct; 43(4):1427-32. PubMed ID: 5395131
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease].
    Leövey A
    Orv Hetil; 1978 Aug; 119(33):2019-21. PubMed ID: 209384
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 17. The production of thyroid-stimulating immunoglobulin (TSI) by lymphocytes from patients with Graves' disease cultured with human thyroid subcellular fractions.
    Sugenoya A; Trokoudes K; Row VV; Volpé R
    J Endocrinol Invest; 1978 Jul; 1(3):245-51. PubMed ID: 583156
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: L.A.T.S. and Graves' disease.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Lancet; 1974 Oct; 2(7884):843. PubMed ID: 4138250
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [LATS and other thyroid-stimulating immunoglobulins in the pathogenesis of Basedow's disease].
    Pinchera A; Baschieri L
    Recenti Prog Med; 1976 Dec; 61(6):790-823. PubMed ID: 1037332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.